Frodsham, United Kingdom

Andrew Smith



Average Co-Inventor Count = 8.0

ph-index = 6

Forward Citations = 58(Granted Patents)


Location History:

  • High Peak, GB (2012 - 2013)
  • Frodsham, GB (2014 - 2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Innovator Profile: Andrew Smith from Frodsham, GB**

Introduction

Andrew Smith is an accomplished inventor based in Frodsham, GB, known for his meaningful contributions to therapeutic compounds. With a total of six patents to his name, he has made significant strides in the fields of medicine and pharmacy, particularly through his innovative work at Pimco 2664 Limited.

Latest Patents

Andrew's latest invention relates to "Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use." This invention is of considerable importance in the field of therapeutic compounds. Specifically, these APSAC compounds are designed for pharmaceutical compositions that treat a variety of conditions, including inflammation, joint destruction, bone loss, and disorders associated with excessive immune system activation. Furthermore, these compounds may assist in addressing inflammatory and autoimmune disorders such as rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease (COPD), and even certain types of cancer. The versatility of his inventions showcases their potential impact in treating serious health conditions.

Career Highlights

Andrew Smith has established himself as a key figure in the realm of pharmaceutical innovation, working diligently at Pimco 2664 Limited. His dedication has led him to develop multiple patents that emphasize the need for advanced therapeutic solutions. His work not only reflects his commitment to innovation but also contributes positively to the healthcare industry.

Collaborations

Throughout his career, Andrew has collaborated with talented professionals in the field, including colleagues Iain Robert Greig and Rose Mary Sheridan. These collaborations have likely fostered an environment of creativity and knowledge sharing, leading to the development of groundbreaking therapeutic advancements.

Conclusion

Andrew Smith represents the spirit of innovation in therapeutic development. His contributions through pioneering patents benefit both the medical community and patients alike. As he continues his journey at Pimco 2664 Limited, the impact of his work is expected to grow, promising advancements in treatment options for various disorders and diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…